Pharmaceutical

MOBILion Systems Launches Proteomics Advisory Board

CHADDS FORD, Pa., Nov. 20, 2024 /PRNewswire/ -- Today MOBILion Systems, Inc., a leader in separation science innovation, announced the formation…

1 month ago

World Class Health Secures $8M in Seed Funding to Expand Concierge Health Benefit with the largest Global Centers of Excellence network

World Class Health's pioneering benefit has achieved a stellar 1.6% readmission rate and delivered a 90+ NPS from nearly 4,000…

1 month ago

VMS BioMarketing Changes its Name to Momentum Life Sciences, Reinforcing its Commitment to Patient Engagement

INDIANAPOLIS, Nov. 20, 2024 /PRNewswire/ -- VMS BioMarketing, a leading provider of patient engagement solutions, today announced its name change…

1 month ago

CND Life Sciences Receives Grant from The Michael J. Fox Foundation to Study Quantification of Cutaneous Phosphorylated Alpha-Synuclein (P-SYN) in People with Parkinson’s Disease

Grant funding will support the new Syn-Q Clinical Study to further investigate the quantification of P-SYN in skin biopsies using CND's…

1 month ago

Teva Takes on Antimicrobial Resistance (AMR): What You Need to Know

NORTHAMPTON, MA / ACCESSWIRE / November 20, 2024 / Antimicrobial resistance (AMR) happens when bacteria no longer respond to antibiotics,…

1 month ago

ALL Study Groups using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria’s 12-Week GLP-1, Diabetes Animal Study

DehydraTECH-liraglutide and a select DehydraTECH-CBD formulation were the top performing groups in the Study outperforming the Rybelsus® control group in…

1 month ago

Safe Supply Streaming Co Ltd. Announces Closing of Acquisition of Drug Lab 118 Ltd

Toronto, Ontario--(Newsfile Corp. - November 20, 2024) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe…

1 month ago

Safe Supply Streaming Co Ltd. Announces Closing of Acquisition of Drug Lab 118 Ltd

Toronto, Ontario--(Newsfile Corp. - November 20, 2024) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe…

1 month ago

MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site

Backed by a Strong Balance Sheet, MIRA Accelerates Toward Becoming a Clinical-Stage Company and Advancing Breakthroughs in Pain and Depression…

1 month ago

BioSyent Releases Financial Results for Q3 and YTD 2024

MISSISSAUGA, Ontario, Nov. 20, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for…

1 month ago